Skip to content
HowShorted

Prestige Consumer Healthcare Inc. short interest in 2021

In 2021, Prestige Consumer Healthcare Inc.'s disclosed short interest ran from 6.91% of shares outstanding on 15 Jan 2021 to 2.43% on 31 Dec 2021, a change of -4.48 percentage points. The year's high was 7.06% on 29 Jan 2021 and its low 2.43% on 31 Dec 2021, averaging 4.75% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 15.80 days on 30 Apr 2021. Full history: Prestige Consumer Healthcare Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Prestige Consumer Healthcare Inc. in 2021

2021 in figures

Start of year
6.91% (15 Jan 2021)
End of year
2.43% (31 Dec 2021)
Change
-4.48 pp
High
7.06% (29 Jan 2021)
Low
2.43% (31 Dec 2021)
Average
4.75%
Highest days to cover
15.80 (30 Apr 2021)
SEC filings marked
8

Every report in 2021

Prestige Consumer Healthcare Inc. short interest in 2021
SettlementShort interestDays to coverFilings since previous
15 Jan 20216.91%11.56
29 Jan 20217.06%1.98
12 Feb 20216.96%7.2810-Q filed, results (8-K)
26 Feb 20216.74%9.07
15 Mar 20216.47%9.76
31 Mar 20216.45%10.47
15 Apr 20216.32%11.25
30 Apr 20216.30%15.80
14 May 20215.77%12.51results (8-K), 10-K filed
28 May 20215.50%12.93
15 Jun 20215.72%13.33
30 Jun 20215.25%8.55
15 Jul 20215.11%15.12
30 Jul 20214.46%10.77
13 Aug 20213.21%5.6710-Q filed, results (8-K)
31 Aug 20213.11%7.44
15 Sep 20213.04%8.34
30 Sep 20213.18%6.02
15 Oct 20213.20%11.02
29 Oct 20212.94%9.05
15 Nov 20212.65%7.3610-Q filed, results (8-K)
30 Nov 20212.65%6.20
15 Dec 20212.65%6.55
31 Dec 20212.43%4.65

See also: Prestige Consumer Healthcare Inc.'s full history · most shorted US stocks of 2021 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.